Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 31, Issue 3, Pages 501-516Publisher
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2019050523
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [P20 GM104936, R01DK115850]
- University of Kansas Department of Medicine
- Carl Gottschalk Award of the American Society of Nephrology
- NIH National Institute of GeneralMedical Sciences Centers of Biomedical Research Excellence (COBRE) [P30 GM103326]
Ask authors/readers for more resources
Background Prolyl-4-hydroxylase domain-containing proteins 1-3 (PH D1 to PHD3) regulate the activity of the hypoxia-inducible factors (HIFs)HIF-1 and HIF-2, transcription factors that are key regulators of hypoxicvascular responses. We previously reported that deficiency of endothelial HIF-2 exacerbated renal ischemia-reperfusion injury, whereas inactivation of endothelial PHD2, the main oxygen sensor, provided renoprotection. Nevertheless, the molecular mechanisms by which endothelial PHD2 dictates AKI outcomes remain undefined. Methods To investigate the function of the endothelial PHD2/HIF axis in ischemic AKI, we examined the effects of endothelial-specific ablation of PHD2 in a mouse model of renal ischemia-reperfusion injury. We also interrogated the contribution of each HIF isoform by concurrent endothelial deletion of both PHD2 and HIF-1 or both PHD2 and HIF-2. Results Endothelial deletion of Phd2 preserved kidney function and limited transition to CKD. Mechanistically, we found that endothelial Phd2 ablation protected against renal ischemia-reperfusion injury by suppressing the expression of proinflammatory genes and recruitment of inflammatory cells in a manner that was dependent on HIF-1 but not HIF-2. Persistence of renoprotective responses after acute inducible endothelial-specific loss of Phd2 in adult mice ruled out a requirement for PHD2 signaling in hematopoietic cells. Although Phd2 inhibition was not sufficient to induce detectable HIF activity in the kidney endothelium, in vitro experiments implicated a humoral factor in the anti-inflammatory effects generated by endothelial PHD2/HIF-1 signaling. Conclusions Our findings suggest that activation of endothelial HIF-1 signaling through PHD2 inhibition may offer a novel therapeutic approach against ischemic AKI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available